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A B S T R A C T
 
Cyanosis in an apparently healthy newborn baby may be caused by hemoglobin variants 
associated with the formation of methemoglobin, collectively known as M hemoglobins. 
They should not be confused with genetic alterations in methemoglobin reductase enzyme 
systems of red cells since treatment and prognosis are completely different. A newborn 
male child was noted to be significantly cyanotic at birth and is the basis for this report. 
Hemoglobin isoelectric focusing, acid and alkaline gel electrophoresis, and HBA/HBB gene 
sequencing were performed for the child, both parents and a sister. The newborn child 
was treated with methylene blue in an intensive care unit fearing that he had a defective 
reductase system and exposure to oxidant drugs or toxins. Newborn hemoglobin screening 
with high performance liquid chromatography was abnormal on the 10th and 45th days 
but no conclusive diagnosis was reached. Cyanosis persisted up to four years of age with 
no other symptoms. Hemoglobin M Iwate [alpha2 87(F8) His>Tyr, HBA2:c.262C>T] was 
detected. It was not present in the child’s presumed mother, father, sister, and brother. The 
analysis of 15 short tandem repeats in the trio demonstrated a de novo mutation occurrence 
(p-value < 1 × 10-8). The family was reassured that no further action was necessary and 
genetic counseling was provided. Methemoglobins should be considered for differential 
diagnosis of cyanosis in newborns even if no familial cases are detected. Except for cosmetic 
consequences, the clinical course of patients with hemoglobin M Iwate is unremarkable.
© 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. 
All rights reserved. 
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Introduction
Methemoglobinemia is the collective name for a clinical 
syndrome caused by an increase of methemoglobin in the 
blood. Broadly speaking, it may be caused by: i) a hemoglobin 
(Hb) variant that keeps the oxidized ferric state in the heme 
pocket and reduces oxygen affinity of the genetically altered 
Hb; ii) congenital deficiencies of nicotinamide adenine 
dinucleotide (NADH)-cytochrome b5 reductase, an essential 
enzyme needed to convert the heme ferric iron to its ferrous 
counterpart, thus making Hb apt to carry oxygen to the tissues; 
iii) an acute drug reaction to oxidizing agents that convert 
Hb to methemoglobin. By far the latter is the most common 
cause of the syndrome. Clinically all these three mechanisms 
will produce central cyanosis which is unresponsive to the 
administration of oxygen.1
Amino acid substitutions within the heme pocket underlie 
all known methemoglobin (M-Hb) variants. Tyrosine replaces 
histidine in close proximity to the heme group at positions 
alpha 87 [F8] (Hb M Iwate), beta 92 [F8] (Hb Hyde Park), alpha 
58 [E7] (Hb M Boston), or beta 63 [E7] (Hb M Saskatoon). Only in 
Hb M Milwaukee-I, the valine residue is replaced by glutamic 
acid at position beta 67 [E11] (http://globin.bx.psu.edu/
hbvar/). For Hb M Iwate, as an example, substitution of the 
normal alpha His F8 side chain for a longer Tyr F8 stabilizes 
the deoxygenated T state and also reduces oxygen affinity of 
the native beta subunit.2 
Children with alpha Hb M variants are symptomatic at 
birth because the interaction of the mutated alpha chain with 
the wild gamma chain is also abnormal and methemoglobin 
formation and cyanosis will follow. Beta variants are generally 
not detected at birth because Hb A concentration is low in 
newborns.
This report aims to describe in detail the clinical, hematological, 
and genetic features of a four-year-old boy with lifelong cyanosis 
who was proved to be heterozygous for a de novo mutation 
resulting in Hb M Iwate [alpha2 87(F8) His>Tyr HBA2:c.262C>T].
Methods
The boy’s family asked for the specialized opinion of one of 
the authors (MBV) about the cyanosis the child had shown 
since birth. Methemoglobinemia was diagnosed at that time 
but the etiology was not elucidated. The boy’s father (33 years 
old) and mother (40 years old) were not consanguineous and 
had a normal daughter, three years older than the proband. 
Ethnic background included Italian, French, and Portuguese 
ancestry. Both parents signed an informed consent form in 
accordance with the Helsinki Declaration.
High performance liquid chromatography (HPLC) of Hb 
performed when the child was 10 and 45 days old were 
retrieved by the Blood Center of Ribeirão Preto, São Paulo, 
Brazil, and kindly sent to us to illustrate the present report. 
Hemoglobin electrophoresis was done in alkaline and acid 
media (SPIFE kits, Helena Laboratories, Beaumont, TX, USA) 
and by isoelectric focusing (IEF; Neonatal Hemoglobin Resolve 
Screen Kit, PerkinElmer Life and Analytical Sciences, Finland). 
Coulter T-890 was used to perform cell blood count. 
Genomic DNA was isolated with the QIAamp® DNA Blood 
Mini Kit, QIAGEN. HBB, HBA2, and HBA1 genes were amplified 
with adequate specific primers. DNA sequencing was done in a 
ABI Prism 3130 Analyzer. A polymerase chain reaction restriction 
fragment length polymorphism (PCR-RFLP) test for the Hb M 
Iwate mutation was also performed. Endonuclease RsaI does 
not restrict the wild HBA2 gene while a restriction sequence 
(GT^AC) is created when the mutation is present.3 A multiplex 
gap PCR assay for alpha-thalassemia deletions was utilized.4 
Parental testing was performed detecting 15 short tandem 
repeats (STR): D8S1179, D21S11, D7S820, CSF1PO, D3S1358, 
TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, 
D18S51, D5S818, and FGA. A specific consent form to perform 
these tests was signed by both parents.
Results
The child was reported to be cyanotic immediately after birth. 
Apgar score was 8 and 10 in the first and fifth minute, respectively. 
Gestational age was 42 weeks and birth weight was 3.6 kg. 
Oxygen delivery was useless to revert the clinical state. Simple 
chest radiography, electrocardiogram, and echocardiogram 
were normal for the age. Although clinically well, the baby was 
transferred to an intensive care unit (ICU). Methemoglobinemia 
was diagnosed on the basis of a brown chocolate blood with a 
methemoglobin relative concentration of 12.5% (normal: below 
3%). Methylene blue injections and oral vitamin C did not revert 
the cyanosis. He was discharged from the ICU after five days 
clinically healthy but with persistent cyanosis. 
Activity of NADH cytochrome b5 reductase assay was not 
available anywhere in Brazil and so was not applied. HPLC 
chromatogram (beta thalassemia short program) when the 
child was 45 days old is depicted in Figure 1. The relative 
concentrations of the peaks were: Hb F 28.4% at retention 
time of 1.16 min, Hb A0 51.6% at retention time of 2.55 min, 
Hb A2 6.5% at retention time of 3.71 min, and unknown Hb 
8.8% at retention time of 4.74 min. Although very faint to be 
graphically reproduced because of the time elapsed since the 
sample was drawn (ten days old) and the type of paper used 
for printing in the newborn screening, the HPLC (sickle cell 
short program) was similar to that when he was 45 days old. 
However, areas under the curve for the observed peaks were 
somewhat different portraying differences in gamma chain 
production between ten and 45 days of life. The unknown 
Hb concentration was 2.6% at retention time of 1.46 min and 
those for Hb F and Hb A0 were 31.1% (retention time of 0.62 
min) and 29.2% (retention time of 0.89 min), respectively. An 
unknown Hb between Hb F and Hb A0 amounted to 12.3% and 
might represent the dimer alphaX/gammaA (abnormal Hb F 
due to a mutated alpha chain).
Except for the mild to moderate cyanosis, the physical 
examination was completely normal when the proband was 
almost four years old. Finger pulse oximetry was 96%. His blood 
cell count was unremarkable: Hb concentration 13.3 g/dL, packed 
red cells 38.3%, mean corpuscular volume 84.2 fL, mean 
corpuscular hemoglobin 29.2 pg, reticulocyte count 1%, white 
cell count 9.1 × 109/L (57% neutrophils, 38% lymphocytes, 3% 
monocytes, and 2% eosinophils), platelets 334 × 109/L. Red 
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cell morphology was normal. Hematologic tests and pulse 
oximetry of other family members were also normal. Very 
recently a male brother was born with no cyanosis. Newborn 
screening tests were normal.
Figure 2 – Hemoglobin electrophoresis 
in alkaline (A) and acid gel (B), and by 
isoelectric focusing (C and D). Hb M Iwate 
is anodal to Hb A in alkaline gel and 
undistinguishable from Hb A in acid gel. Its 
color is brown in contrast to the vivid red 
of Hb A before trichloroacetic acid is applied 
to the isoelectric focusing gel (C). It runs 
between Hb F and Hb S (closer to Hb F) after 
the gel has been fixed and dried (D).
Figure 1 – High performance liquid chromatography chromatogram 
(beta thalassemia short program) when the child was 45 days old. 
The original line of the chromatogram was traced over to make 
it clearer 4 years after printing on a thermo-sensitive paper. The 
relative concentration of Hb A is already higher than that of Hb F, 
as expected. The estimated relative concentration of Hb M Iwate 
(area under the peak at the retention time of 4.74 min) is 8.8% 
[image kindly sent by the Blood Center of Ribeirão Preto, São 
Paulo, Brazil]
Figure 2 depicts alkaline and acid gel electrophoresis and 
IEF from the sample drawn for this report. Note that Hb M 
Iwate is clearly separated from Hb F and Hb A in both the 
alkaline gel procedure and IEF, but indistinguishable from Hb 
A in acid medium. The estimated relative concentration of Hb 
M Iwate read in the alkaline gel was 28%. Hb A2 concentration 
was 3% and Hb F 1.9%. In IEF, the color of Hb M Iwate is brown 
before trichloroacetic acid is applied to the IEF gel, in contrast 
to the vivid red color of Hb A (Figure 2C).
Figure 3A shows the electropherogram of the boy’s 
HBA2 gene sequencing. PCR-RFLP with RsaI of all members 
of the family is depicted in Figure 3B. The mutation 
underlying heterozygous Hb M Iwate [alpha2 87(F8) His>Tyr 
HBA2:c.262C>T] was detected through sequencing and PCR-
RFLP only in the proband. Homozygous thymidine (T/T) 
nucleotide polymorphism rs2541669 (NG_000006.1:g.33004 
C>T) was detected in the proband and his father, and in 
heterozygous state (C/T) in his mother and sister (Figure 3B). 
The seven most common α-thalassemia deletion mutations4 
were absent in all family members.
Parental testing yielded a combined paternity index of 
221,784,816. The probability of paternity is, therefore, 99.999999%. 
The STR that contributed mostly to the index was D19S433 with 
a paternity index of 29.5899: the proband was genotyped as 14-
16.2, his mother as 14-16, and his father as 14-16.2.
Discussion
Hereditary nigremia at Iwate Prefecture had been known by 
Japanese doctors for 160 years before a new M Hb was de-
scribed in 1960 as the etiology of the disease5. Since then 
there were several Japanese studies that have characterized 
the interesting chemical properties of Hb M Iwate.6-7 In the 
vivid description of the clinical picture by Professor Shibata, 
“The patients with this disease are cyanotic from childhood, 
looking like a man who has been swimming in a cold water 
pool for a long time”.6 As demonstrated in the present study, 
no ill effect on health has been documented before, even in 
patients who had lived to adulthood.5,8,9 
The amino acid substitution His>Tyr was demonstrated 
in 1964.10 The other names for Hb M Iwate as can be read at 
HbVar site (http://globin.bx.psu.edu/hbvar/) are M-Kankakee,8 
M-Oldenburg,11 and M-Sendai (no reference found). 
The mutation underlying Hb M Iwate in the HBA1 gene was 
reported only in 1987.3 Subsequently it was confirmed either 
in HBA112 or in HBA2.13 Specific amplification of the proband’s 
alpha genes in the present study demonstrated that the mu-
tation took place in HBA2. Homozygous T polymorphism 
rs2541669 (minor allele count T= 0.372/810) does not add any 
pathologic consequence as suggested by the normal clinical 
state of the homozygous T father.
On the basis of negative family histories for cyanotic 
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sequencing is necessary for the identification of abnormal 
variants. Except for cosmetic consequences, the clinical 
course of patients with Hb M Iwate is unremarkable.
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